Sanofi (SNY) Other Non Operating Income (2011 - 2016)
Sanofi's (SNY) quarterly Other Non Operating Income came in at -$44.3 million in Q4 2016, down 125.08% year-over-year from $176.5 million in Q1 2016, and down 46.89% quarter-over-quarter from -$30.1 million in Q3 2016.
Analysis
Sanofi (SNY) Other Non Operating Income (2011 - 2016) Analysis & Trends
Sanofi has disclosed Other Non Operating Income across 6 years of filings, most recently posting -$44.3 million for Q4 2016.
- In Q4 2016, Other Non Operating Income fell 125.08% year-over-year to -$44.3 million; the TTM figure through Dec 2016 stood at -$149.3 million (down 142.06% YoY), while the FY2016 annual figure was -$149.5 million, down 353.86% from the prior year.
- Other Non Operating Income came in at -$44.3 million for Q4 2016 at Sanofi, down from -$30.1 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $679.2 million in Q4 2013 to a low of -$378.7 million in Q4 2014.
- Average Other Non Operating Income over 5 years is $20.9 million, with a median of -$4.9 million recorded in 2014.
- Year-over-year, Other Non Operating Income jumped 426.04% in 2012 and sank 2931.16% in 2016.
- Over 5 years, Other Non Operating Income stood at -$249.0 million in 2012, then surged by 372.76% to $679.2 million in 2013, then plunged by 155.76% to -$378.7 million in 2014, then surged by 146.6% to $176.5 million in 2015, then sank by 125.08% to -$44.3 million in 2016.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$44.3 million in Q4 2016, -$30.1 million in Q3 2016, and -$42.9 million in Q2 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | -44.27 Mn |
| Sep 30, 2016 | -30.14 Mn |
| Jun 30, 2016 | -42.94 Mn |
| Mar 31, 2016 | -31.99 Mn |
| Dec 31, 2015 | 176.47 Mn |
| Sep 30, 2015 | 100.11 Mn |
| Jun 30, 2015 | 77.36 Mn |
| Mar 31, 2015 | 1.13 Mn |
| Dec 31, 2014 | -378.70 Mn |
| Sep 30, 2014 | -59.73 Mn |
| Jun 30, 2014 | -170.11 Mn |
| Mar 31, 2014 | -10.96 Mn |
| Dec 31, 2013 | 679.18 Mn |
| Sep 30, 2013 | 90.10 Mn |
| Jun 30, 2013 | 99.24 Mn |
| Mar 31, 2013 | 54.13 Mn |
| Dec 31, 2012 | -249.00 Mn |
| Sep 30, 2012 | 107.55 Mn |
| Jun 30, 2012 | 93.80 Mn |
| Mar 31, 2012 | -43.27 Mn |